全文获取类型
收费全文 | 20310篇 |
免费 | 2471篇 |
国内免费 | 457篇 |
专业分类
耳鼻咽喉 | 405篇 |
儿科学 | 661篇 |
妇产科学 | 132篇 |
基础医学 | 1884篇 |
口腔科学 | 123篇 |
临床医学 | 2933篇 |
内科学 | 2558篇 |
皮肤病学 | 33篇 |
神经病学 | 6712篇 |
特种医学 | 356篇 |
外国民族医学 | 1篇 |
外科学 | 855篇 |
综合类 | 2061篇 |
预防医学 | 1677篇 |
眼科学 | 519篇 |
药学 | 1309篇 |
13篇 | |
中国医学 | 607篇 |
肿瘤学 | 399篇 |
出版年
2024年 | 124篇 |
2023年 | 572篇 |
2022年 | 844篇 |
2021年 | 1262篇 |
2020年 | 1211篇 |
2019年 | 1237篇 |
2018年 | 1151篇 |
2017年 | 1199篇 |
2016年 | 1090篇 |
2015年 | 943篇 |
2014年 | 1588篇 |
2013年 | 2123篇 |
2012年 | 1199篇 |
2011年 | 1099篇 |
2010年 | 869篇 |
2009年 | 871篇 |
2008年 | 809篇 |
2007年 | 775篇 |
2006年 | 698篇 |
2005年 | 510篇 |
2004年 | 431篇 |
2003年 | 415篇 |
2002年 | 328篇 |
2001年 | 260篇 |
2000年 | 209篇 |
1999年 | 162篇 |
1998年 | 134篇 |
1997年 | 155篇 |
1996年 | 127篇 |
1995年 | 99篇 |
1994年 | 88篇 |
1993年 | 84篇 |
1992年 | 74篇 |
1991年 | 65篇 |
1990年 | 51篇 |
1989年 | 55篇 |
1988年 | 44篇 |
1987年 | 48篇 |
1986年 | 42篇 |
1985年 | 39篇 |
1984年 | 33篇 |
1983年 | 17篇 |
1982年 | 23篇 |
1981年 | 18篇 |
1980年 | 13篇 |
1979年 | 14篇 |
1978年 | 10篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
目的:研究癫患者认知功能的影响因素。方法:对166例癫患者进行认知评定。认知评定工具:听觉词语测验、逻辑记忆测验、数字符号转换测验、Stoop字色干扰测验、连线测验、言语流畅性测验、Rey-Osterrieth复杂图片测验及Boston命名测验。影响因素与认知功能评分之间采用一元线性相关及多元逐步回归分析。结果:患者年龄、性别、文化程度、起病年龄、病程、发作频率、发作持续时间、全身强直阵挛发作(GTCS)、复杂部分性发作(CPS)及抗癫药物数量与患者的认知功能有相关性。结论:癫患者的起病年龄与其认知损害成正比,病程越长对癫患者的认知损害越明显,原发或继发全身性强直阵挛发作与言语功能损害、复杂部分性发作与言语记忆损害之间的关系密切,用药种类与记忆、注意力以及精神运动能力的损害有关。 相似文献
93.
亚低温冬眠疗法治疗重度脑挫伤的临床研究 总被引:3,自引:0,他引:3
目的探讨亚低温冬眠疗法对重度脑挫伤病人的脑保护机理及临床疗效。方法46例重度脑挫伤患者(GCS≤8分)随机分为亚低温冬眠治疗组和常温治疗组。其中亚低温冬眠组22例,入院后4 ̄12h内行亚低温冬眠治疗,输液泵持续静脉点滴冬眠合剂,将肛温控制在32 ̄35℃,亚低温冬眠治疗4 ̄7d,同时检测颈动脉和颈静脉血气、电解质变化、血糖及生命体征等指标。常温组24例除未行亚低温冬眠治疗外,其余综合治疗及监测方法同亚低温冬眠组。两组病人均于伤后3个月根据GOS预后评分判定疗效。结果与常温组比较,亚低温冬眠治疗组脑氧耗明显降低,高血糖情况显著下降,生命体征及电解质等无明显差异,无严重并发症,死残率明显降低,预后显著改善。结论亚低温冬眠疗法具有显著的脑保护作用,临床应用于重度脑挫伤救治安全有效,无严重并发症。 相似文献
94.
Allen Cato III Linda E. Gustavson Jiang Qian Tawakol El-Shourbagy Edward A. Kelly 《Epilepsia》1998,39(1):43-47
Summary: Purpose: We wished to determine the effect of renal impairment on the pharmacokinetics and tolerability of the new antiepileptic drug tiagabine (TGB).
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
95.
"Chronic painter''s syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls 总被引:4,自引:0,他引:4
Twenty solvent-exposed workers, most of them painters, had been diagnosed as cases of toxic encephalopathy in 1978/79. Two years later they were re-examined with an extensive battery of neuropsychological tests. Their performance was unchanged on retesting. We have now compared their test results with those of non-exposed control subjects. Previous impressions of significant intellectual impairment in the solvent-exposed patients could not be confirmed when the influence of age, education, and intelligence was taken into consideration. The present group with presumed toxic encephalopathy is assumed to be representative of other patients who were similarly diagnosed in our department. The presently reanalyzed cases had been diagnosed as brain damaged and reported as such in the literature. Thus, they may have contributed to the formation of the concept of the "chronic painters' syndrome" with dementia. 相似文献
96.
脑卒中后认知障碍(PSCI)是脑卒中患者常见的并发症,严重影响患者的生活质量。目前,PSCI在临床治疗中尚未发现有效的针对性治疗措施。大量研究证实核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎症小体的活化在PSCI中起关键作用,且对其进行的许多抑制性治疗显示出了改善认知障碍的功效。为此,本文总结了NLRP3炎症小体的活化和影响因素及其与PSCI的关系,发现在PSCI的细胞和动物模型中,针对NLRP3或其炎症小体成分的抑制措施可以减轻炎性反应和相应的病理特征,从而促进其认知功能的恢复,因此,靶向NLRP3炎症小体可能是PSCI治疗的新趋势。然而到目前为止,尽管许多药物和治疗措施已成功鉴定出能够抑制NLRP3炎症小体的活化,但其在临床中的治疗效果和安全性仍有待进一步验证。 相似文献
97.
背景 主观认知下降(SCD)是阿尔茨海默病(AD)早期预防的目标阶段,AD与慢性病共病关系密切,但二者间相关性尚不十分明确。目的 探究老年人SCD与慢性病共病的相关性,为AD早期预防和干预提供理论依据。方法 于2021年1月至2022年6月,在广州市城市生活小区和养老机构以便利抽样法抽取≥60岁的老年人612例。采用基础版蒙特利尔认知评估量表(MoCA-B)、临床痴呆量表(CDR)、Hachinski缺血指数量表(HIS)评定客观认知功能水平,通过SCD标准诊断框架和SCD问卷(SCD-Q9)进行分组,将整体客观认知水平无异常、符合SCD标准诊断框架和SCD-Q9≥5分的老年人分入SCD组,将整体客观认知功能无异常和SCD-Q9<5分的老年人为认知无异常(CN)组。采用一般资料问卷收集老年人的社会人口学(性别、年龄、居住地、受教育年限、婚姻状况、退休前职业类型、月收入)和健康相关资料[体质指数、腰围、吸烟习惯、饮酒习惯、饮茶习惯、锻炼频率、午觉习惯及平均时长、睡眠质量、抑郁及焦虑症状、日常生活活动能力(ADL)],其中睡眠质量、抑郁症状、焦虑症状及ADL分别采用匹兹堡睡眠指数量表... 相似文献
98.
Quantification of motor deficit in Parkinson's disease with a motor performance test series 总被引:2,自引:0,他引:2
M. M. Pinter R. J. Helscher Ch. O. J. Nasel E. Riedl G. Schnaberth 《Journal of neural transmission (Vienna, Austria : 1996)》1992,4(2):131-141
Summary It was the purpose of the present study to quantify the expected motor deficit in parkinsonian patients with the computer assisted Motor Performance Test Series (MPS), version 05.87 by Schuhfried (1987) and to examine which of the motor test variables found correlate at a significance level of p<0.01 with items of motor examination recorded at neurological examination and activities of daily living of the Unified Parkinson's Disease Rating Scale (UPDRS), version 3.0.38 patients with idiopathic Parkinson's disease (PD) stages I–IV according to Hoehn and Yahr, aged 41 to 73 years were studied. The study design, i.e. initial rating by the physician followed immediately by testing of motor function with MPS was strictly adhered to in each patient.Physician's rating of rigor and the scores of the semiquantitative tests (finger taps, hand movements and alternating movements) as expression of hypokinesia and the activities of daily living correlated with the 3 factors of the Motor Performance Test Series at a highly significant level independent of disease stage. Tremor is only partly and never significantly reflected in the motor data measured. Stages I–II and II–IV (Hoehn and Yahr) differ significantly in the representative data of the Motor Performance Test Series.The results of the study support the assumption that MPS is a valid instrument for quantitative measurement of the motor deficit in parkinsonian patients, but that only some subtests are pathognomonic. 相似文献
99.
In his recent formulations of rational emotive therapy (RET), Ellis (1985) has increasingly emphasized what he believes to be the central role of necessitous thinking or musturbation in the development of depression. In his most recent article (Ellis, 1987), he suggests that necessitous thinking is the primary cognitive component of depression and that RET stands alone in its recognition of the role of this cognitive element. The present study addressed three issues raised by Ellis's paper: (1) Clarify whether necessitous thinking has been neglected by other cognitive theorists, (2) test empirically the role of necessitou thinking in depression relative to other established cognitive constructs, e.g., the cognitive triad (Beck, 1967), and (3) determine whether necessitous thinking is particularly salient in depression as compared with other forms of psychopathology. It was predicted that necessitous thinking would be found in other forms of psychology in addition to depression, and this was confirmed. The results are discussed as highlighting the importance of empirically testing theoretical predictions.From the Foundation for Cognitive Therapy. 相似文献